Biosensor-Based Nanodiagnosis of Carcinoembryonic Antigen (CEA): an Approach to Classification and Precise Detection of Cancer Biomarker

The precise detection of cancer biomarkers is a principal aspect of effective diagnosis, monitoring, and therapeutics. Carcinoembryonic antigen (CEA) is a protein normally found in very small amounts in the blood of adults. CEA blood levels can be elevated in benign diseases and certain types of can...

Full description

Saved in:
Bibliographic Details
Published in:BioNanoScience 2024-03, Vol.14 (1), p.429-446
Main Authors: Hariri, Maryam, Alivirdiloo, Vahid, Ardabili, Nastaran Safavi, Gholami, Sarah, Masoumi, Sajjad, Mehraban, Mohammad Reza, Alem, Mahsa, Hosseini, Reza Shah, Mobed, Ahmad, Ghazi, Farhood, Alipourfard, Iraj
Format: Article
Language:English
Subjects:
Antigens
Biological and Medical Physics
Biomarkers
Biomaterials
Biophysics
Biosensors
Blood
Blood levels
Cancer
Carcinoembryonic antigen
Circuits and Systems
Colorectal carcinoma
Diagnosis
Differential diagnosis
Engineering
Monitoring
Nanomaterials
Nanotechnology
Telemedicine
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The precise detection of cancer biomarkers is a principal aspect of effective diagnosis, monitoring, and therapeutics. Carcinoembryonic antigen (CEA) is a protein normally found in very small amounts in the blood of adults. CEA blood levels can be elevated in benign diseases and certain types of cancer. The CEA test is most commonly used to identify a significantly frequent cancer, colorectal cancer. It has decisive clinical value in monitoring, differential diagnosis, disease, and assessment of therapeutic effects. Therefore, it is important to develop a sensitive and simple CEA detection method to diagnose cancer and improve patient survival accurately. Biosensing has great advantages for early disease detection due to its rapid response, high sensitivity, and convenient operating characteristics. Based on several studies, biosensors seem to be new and promising paths in the future of medical oncology. The main purpose of this study is to introduce and discuss the recent nanodiagnostic biosensors developed since 2018. Therefore, the readers of this study will be introduced to the latest biosensors, the various nanomaterials used in them, and their analytical characteristics. Graphical abstract
ISSN:2191-1630
2191-1649
DOI:10.1007/s12668-023-01250-7